Joseph L. Moskowitz Sells 1,000 Shares of Aflac Incorporated (NYSE:AFL) Stock

Aflac Incorporated (NYSE:AFL - Get Free Report) Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aflac Price Performance

Shares of AFL stock traded down $0.61 during trading hours on Tuesday, hitting $106.15. The company had a trading volume of 216,660 shares, compared to its average volume of 2,013,632. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The firm has a market capitalization of $58.02 billion, a price-to-earnings ratio of 11.04, a PEG ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The firm's fifty day moving average is $105.15 and its 200 day moving average is $107.73.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Institutional Investors Weigh In On Aflac

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AFL. Pettinga Financial Advisors LLC acquired a new position in Aflac during the 3rd quarter worth $203,000. CWA Asset Management Group LLC bought a new position in Aflac in the third quarter valued at about $810,000. XML Financial LLC acquired a new stake in Aflac in the third quarter worth about $207,000. Covestor Ltd boosted its stake in shares of Aflac by 41.8% in the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock valued at $41,000 after purchasing an additional 107 shares during the last quarter. Finally, Axxcess Wealth Management LLC boosted its stake in shares of Aflac by 95.9% in the 3rd quarter. Axxcess Wealth Management LLC now owns 6,143 shares of the financial services provider's stock valued at $687,000 after purchasing an additional 3,007 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Evercore ISI cut their price objective on shares of Aflac from $104.00 to $102.00 and set an "underperform" rating on the stock in a research report on Wednesday, December 4th. Morgan Stanley raised their price target on shares of Aflac from $98.00 to $105.00 and gave the company an "equal weight" rating in a report on Friday, February 28th. StockNews.com upgraded shares of Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Keefe, Bruyette & Woods reduced their price target on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research report on Wednesday, February 12th. Finally, Wells Fargo & Company decreased their price target on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 19th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Aflac presently has a consensus rating of "Hold" and an average target price of $103.36.

Remove Ads

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.